22 February 2024
Target Healthcare REIT plc and its subsidiaries
("Target Healthcare" or "the Group")
Notice of Half Year Results
Target Healthcare (LSE: THRL), the UK listed specialist investor in modern, purpose-built care homes, will announce its half year results for the six months ended 31 December 2023 on Tuesday 12 March 2024.
A presentation for investors and analysts will be held on the morning of the results at 09.00am at
FTI Consulting's offices: 200 Aldersgate, Aldersgate Street, London EC1A 4HD.
A live webcast will also be available.
For more details, please get in touch with FTI Consulting at Katrine.Isaac@fticonsulting.com.
Enquiries:
| | |
| | |
| Target Fund Managers: Kenneth MacKenzie Gordon Bland | Tel: +44 (0)1786 845 912
|
|
FTI Consulting: Dido Laurimore Richard Gotla Talia Shirion |
Tel: +44 (0)20 3727 1000 |
| | |
Notes to editors:
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.
The Group's portfolio at 31 December 2023 comprised 98 assets let to 32 tenants with a total value of £911.1 million.
The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
